Published in
Elsevier, American Journal of Kidney Diseases, 3(66), p. 441-449, 2015
DOI: 10.1053/j.ajkd.2015.03.024
Links
Tools
Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes
Journal article published in 2015 by
Mark E. Cooper,
Vlado Perkovic 
,
Janet B. McGill,
Per-Henrik Groop,
Christoph Wanner,
Julio Rosenstock,
Uwe Hehnke,
Hans-Juergen Woerle,
Maximilian von Eynatten
,
Janet B. McGill,
Per-Henrik Groop,
Christoph Wanner,
Julio Rosenstock,
Uwe Hehnke,
Hans-Juergen Woerle,
Maximilian von Eynatten
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 